Long-term follow-up of diabetic and non-diabetic patients with chronic hepatitis C

We thank Zhu et al. (1) for the interest showed towards our recent paper (2) on the long-term impact of the Sustained Virologic Response (SVR) on diabetes mellitus (DM) in patients with chronic hepatitis C treated with Direct Acting Antiviral Agents (DAA).